Breast Cancer

Oncology nurse Tammy Zinn, an Extraordinary Healer finalist, expanded support through wish-granting programs, counseling and survivorship care for patients with cancer.

Dr. Erica Mayer of Dana-Farber highlights new data on chemotherapy-free HER2+ treatment, ctDNA monitoring and oral SERDs at ESMO Breast 2026.

A survivor shares why advocating for a mammogram past age 75 led to a crucial second diagnosis and why family history means staying vigilant for life.

New research suggests biologic aging and neighborhood-related stress may affect how aerobic exercise influences cognition after breast cancer treatment.

A moving journey through breast cancer, discovering that vulnerability is courage and a diagnosis doesn't have to define your spirit or faith.

The FDA approved Enhertu for certain patients with HER2-positive early-stage breast cancer before and after surgery based on DESTINY trial data.

My experience with cancer has affected the way I think about the health of my pets. Whereas the old me was more fatalistic, the survivor in me would go an extra mile to save a beloved creature.

ctDNA liquid biopsies detect breast cancer at molecular levels to guide personalized therapy and monitor for recurrence or progression.

Experts urge caution with ctDNA testing in early-stage breast cancer, citing "molecular anxiety" and a lack of clear clinical data on survival outcomes.

Learn about the FDA approval of Veppanu, the first PROTAC for ER+/HER2- metastatic breast cancer with ESR1 mutations.

A cancer survivor reflects on the profound power of physician communication, highlighting how words can either validate hope or deepen patient pain.

A breast cancer survivor shares how faith and community prayer provided unexplainable peace and a new mission to offer hope to others in need.

Following the FDA approval of Veppanu for ESR1-mutant breast cancer, Dr. Komal Jhaveri explains this new therapy that destroys cancer receptors.

Phase 3 VIKTORIA-1 trial shows gedatolisib triplet therapy significantly extends progression-free survival for HR+/HER2- advanced breast cancer.

Learn about rare phyllodes tumors, from benign to malignant grades, including surgical options, recovery and key questions for your oncology team.

Following FDA approval, Veppanu (vepdegestrant) provides a new oral treatment option for patients with ESR1-mutated, ER+/HER2- metastatic breast cancer.

Summer, with its promise of warmth and freedom, can present unexpected challenges for breast cancer survivors navigating life after a mastectomy.

New AHN research shows high-intensity resistance training is safe and essential for breast cancer survivors to gain strength and functional mobility.

Phase 3 trial shows Datroway significantly extended overall and progression-free survival in patients with previously untreated, advanced TNBC ineligible for immunotherapy.

Dr. Nguyen shares how breast cancer patients in rural areas can overcome travel barriers and confidently discuss clinical trials with their doctors.

Learn why timing and muscle health are vital when using GLP-1 therapy for weight management during and after breast cancer treatment.

Learn about Paget disease of the breast, a rare cancer affecting the nipple. Explore symptoms, diagnostic steps and common treatment options.

Breast cancer survivor Anna Wassman-Cox discusses the Onco-Ballet Foundation and how dance provides healing and community for Stage IV patients.

Learn about breast angiosarcoma, a rare blood vessel cancer. Discover the signs of primary and secondary cases to help guide your oncology discussion.

Moving into a new home often means sorting through years of belongings. Sometimes, hidden in a box, we uncover pieces of the past that force us to confront what we’ve endured.